White Paper
The Largest Data-driven IG Study
InCircle’s unique approach is backed by INSIGHTS, the largest data-driven IG study to date. The study was overseen by eight physicians with expertise in neuromuscular medicine who independently reviewed all written notes, lab data, imaging reports and electrodiagnostic studies supplied to insurance companies to secure IG coverage approval for 248 patients.
INSIGHTS Study Exposes Inaccuracies
Patients were referred for IG therapy by 154 physicians in 26 states, and the findings were telling:
Data Supports New Prescribing Model
InCircle combines the knowledge of key opinion leaders with the data needed to make the right prescribing decision. This model can not only lower the rates of misdiagnosis and the overutilization of IG, it can also be instrumental in minimizing waste and lowering costs.
HOW IT WORKS
Our proprietary algorithm is backed
by disease state experts on staff.
Our proprietary algorithm is backed by disease state experts on staff.
At InCircle Review, we’ve reinvented how specialty drug cases are reviewed and approved from the ground up. We review every case so you don’t have to.
Submit Your Records
Securely submit all examination, test results, and other documentation into the InCircle Review Portal (which can be added to a payor website).
Data is Reviewed
Our proprietary algorithm and disease state experts
verify case data against payor policies and a final
recommendation is created based on the analysis.
Our proprietary algorithm and disease state experts verify case data against payor policies and a final recommendation is created based on the analysis.
Results are Shared
The data leading to the recommendation, along with a summary of findings, is made available, with key stakeholders and care providers alerted as necessary.
You Save Money and
Improve Outcomes
You Save Money and Improve Outcomes
The InCircle Review model helps you save on your drug spend while improving patient outcomes without unnecessary therapy, time, or costs.
InCircle Review aligns longitudinal patient, diagnostic, and insurance data to streamline the prescribing process and help ensure patients receive the right drug at the right time while providing consistent and transparent decision-making for all stakeholders.
By leveraging the knowledge of a panel of expert reviewers who have access to real data, InCircle Review alleviates the burden on prescribing physicians who are currently tasked with making accurate diagnoses without access to the data and longitudinal records to do so.
In addition, InCircle Review gives payors a transparent and consistent view of the decision-making process, while providing employers with a desperately needed solution to control drug spend.
